Cwa Asset Management Group, LLC Haleon PLC Transaction History

Cwa Asset Management Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.02 - $8.67 $1,772 - $1,916	-221 Reduced 1.38%	15,779 $133,000
Q4 2023 Feb 13, 2024	BUY	$7.78 - $8.62 $1,719 - $1,905	221 Added 1.4%	16,000 $131,000
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $2,119 - $2,413	-270 Reduced 1.68%	15,779 $131,000
Q2 2023 Jul 27, 2023	BUY	$8.04 - $9.0 $562 - $630	70 Added 0.44%	16,049 $134,000
Q1 2023 Apr 17, 2023	BUY	$7.57 - $8.37 $1,165 - $1,288	154 Added 0.97%	15,979 $130,000
Q4 2022 Jan 09, 2023	SELL	$5.96 - $8.06 $1,633 - $2,208	-274 Reduced 1.7%	15,825 $0
Q3 2022 Nov 09, 2022	BUY	$5.63 - $7.5 $90,637 - $120,742	16,099 New	16,099 $98,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwa Asset Management Group, LLC with notifications on news.